Therabel is a privately-owned pharmaceutical company, with a European heritage stretching back to 1945. It is an organization which has achieved extensive international expansion by means of both acquisitions and organic growth. Product portfolio is primarily generated through collaborations with other pharmaceutical companies. Thus, Therabel’s partnered products consistently benefit from the highest level of commitment and focus. Therabel objective is to provide safe and effective therapeutic solutions developed by our partners, making these available to European healthcare professionals and patients through our know-how in market access and commercialization.